✦ LIBER ✦

BCR-ABL-negative chronic myeloid leukemia

✍ Scribed by Sonja Burgstaller; Andreas Reiter; Nicholas C. P. Cross

Book ID: 107540166
Publisher: Current Science Inc.
Year: 2007
Tongue: English
Weight: 406 KB
Volume: 2
Category: Article
ISSN: 1558-8211
DOI: 10.1007/s11899-007-0011-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hyperfunction of neutrophils in a patien

Hyperfunction of neutrophils in a patient with BCR/ABL negative chronic myeloid leukemia : A case report with in vitro studies

✍ Kiyoshi Watari; Arinobu Tojo; Tokiko Nagamura-Inoue; Masaaki Matsuoka; Seiji Iri 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 257 KB 👁 3 views

3′ BCR recombines with IGL locus in BCR-

3′ BCR recombines with IGL locus in BCR-ABL–positive Philadelphia-negative chronic myeloid leukemia

✍ Suzanne M. Benjes; Lynn J. Millow; Aaron R. Jeffs; Stephen J. Sowerby; Anthony E 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 235 KB

We have isolated the 3Ј BCR breakpoint junction of a complex BCR-ABL1 rearrangement found in leukemic cells with a cytogenetically normal karyotype, and the corresponding germline fragment that spanned the 3Ј BCR recombination site. Fluorescence in situ hybridization localized the 3Ј BCR recombinati

Chronic myeloid leukemia 2011: Successes

Chronic myeloid leukemia 2011: Successes, challenges, and strategies—Proceedings of the 5th annual BCR-ABL1 positive and BCR-ABL1 negative myeloproliferative neoplasms workshop

✍ Tariq I. Mughal; Jerald P. Radich; Richard A. Van Etten; Alfonso Quintás-Cardama 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

Molecular response to imatinib in patien

Molecular response to imatinib in patient with Ph negative p190 BCR–ABL transcript positive chronic myeloid leukemia with cyclic leukocytosis

✍ M. Radojkovic; S. Ristic; S. Pavlovic; M. Colovic 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 181 KB

An atypical case of Philadelphia (Ph) negative, e1a2 BCR-ABL transcript positive chronic myeloid leukemia (CML) characterized with cyclic periodic leukocytosis and spontaneous remissions is reported. The patient was treated with imatinib and good hematology response with molecular remission was achi

A two-color BCR–ABL probe that greatly r

A two-color BCR–ABL probe that greatly reduces the false positive and false negative rates for fluorescence in situ hybridization in chronic myeloid leukemia

✍ F. H. Grand; A. Chase; S. Iqbal; D. X. Nguyen; J. L. Lewis; S. B. Marley; R. J. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 274 KB 👁 1 views

The t(9;22) translocation resulting in the fusion of BCR and ABL genes is pathognomonic in chronic myeloid leukemia (CML) and may be investigated at the molecular level using fluorescence in situ hybridization (FISH). Two-color BCR-ABL probes visualizing one fusion signal (1F FISH) have high false p

Isolated thrombocytosis as first sign of

Isolated thrombocytosis as first sign of chronic myeloid leukemia with e6a2 BCR/ABL fusion transcript, JAK2 negativity and complete response to imatinib

✍ Massimo Breccia; Laura Cannella; Daniela Diverio; Paola Streponi; Mauro Nanni; C 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 91 KB

Since very few unusual BCR/ABL fusion transcripts in chronic myeloid leukemia have been reported, no clear evidence exists concerning their clinical and prognostic implications. We describe here a CML case with normal karyotype at standard cytogenetics and an atypical e6a2 BCR/ABL fusion transcript,